Aspirin for the prevention of cognitive decline in the Elderly: a Neuro-Vascular Imaging Study (ENVIS-ion) from ASPREE

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/471460

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The ENVIS-ion trial will examine whether Aspirin is effective in delaying the onset of worsening of thinking and memory abilities in healthy older adults. Magnetic resonance imaging (MRI) of brain structure will detect markers of early worsening of thinking and memory abilities. Blood vessels in the back of the eye (retina) share many features with vessels in the brain. We will compare whether aspirin lessens changes over time of features shown with brain MRI and retinal photography.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2015

Funding Scheme: NHMRC Project Grants

Funding Amount: $1,341,232.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Geriatrics And Gerontology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

MRI (see magnetic resonance imaging) | ageing and dementia | cognitive decline | cognitive outcome | magnetic resonance imaging | preventative medicine | randomised controlled trial

Related Links